Hurvitz Chaim (CIK 0001630542)

Latest company ownership

Shares held
1,644,793
Last filed at
Sep 11, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 30, 2023 Sep 11, 2023 NRX Pharmaceuticals, Inc. Director Buy 83.8 +70,000 3.26% $20.1K
Nov 16, 2022 Nov 23, 2022 NRX Pharmaceuticals, Inc. Director Buy 97.5 +500,000 100.00% $514.9K
Nov 16, 2022 Nov 21, 2022 NRX Pharmaceuticals, Inc. Director Buy 97.5 +500,000 30.40% $514.9K